TY  - JOUR 
AU  - Ordóñez García, José Luis
AU  - Amaral, Ana Teresa
AU  - Montero Carcaboso, Ángel
AU  - Herrero Martín, David
AU  - García Macías, María del Carmen
AU  - Alonso López, Diego
AU  - Pascual Pastor, Guillem
AU  - San Segundo, Laura
AU  - Vila Ubach, Mónica
AU  - Rodrigues, Telmo
AU  - Fraile, Susana
AU  - Teodosio, Cristina
AU  - Mayo Iscar, Agustín
AU  - Aracil, Miguel
AU  - Galmarini, Carlos María
AU  - Martínez Tirado, Oscar
AU  - Mora Graupera, Jaume
AU  - Álava, Enrique de
PY  - 2015
SN  - 1949-2553
UR  - http://uvadoc.uva.es/handle/10324/21677
AB  - Recent preclinical evidence has suggested that Ewing Sarcoma (ES) bearing
EWSR1-ETS fusions could be particularly sensitive to PARP inhibitors (PARPinh) in
combination with DNA damage repair (DDR) agents. Trabectedin is an antitumoral
agent that...
LA  - eng
PB  - Impact Journals
KW  - Sarcoma
TI  - The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
DO  - 10.18632/oncotarget.4303
ER  -